Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS) SHH

10.06

-0.23(-2.24%)

Updated at September 26 03:00PM

Currency In CNY

Valuation

Market Cap8.26B
Enterprise Value7.44B
P/E Ratio42.86
PEG Ratio-1.07
Price/Sales Ratio10.58
Price/Book Ratio3.47
Enterprise/Revenue9.55
Enterprise/EBITDA26.63

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.25
Operating Margin0.32

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue795.29M
Revenue/Share0.94
Gross Profit431.31M
EBITDA311.62M
Net Income206.79M
Diluted EPS0.25

Balance Sheet

Total Cash1.15B
Total Cash/Share1.38
Total Debt330.28M
Total Debt/Equity0.14
Current Ratio2.83
Book Value Per Share2.9

Price History

52-Week Change20.62
52-Week High12.51
52-Week Low6.94
Moving Average 50 Days10.95
Moving Average 200 Days9.24

Statistics

Average Volume26.33M
Shares Outstanding830.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.99
Payout Ratio0.43
Last Split Factor7:5
Last Split DateJuly 12, 2024